Last reviewed · How we verify
FX005
At a glance
| Generic name | FX005 |
|---|---|
| Sponsor | Pacira Pharmaceuticals, Inc |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- FX005 CI brief — competitive landscape report
- FX005 updates RSS · CI watch RSS
- Pacira Pharmaceuticals, Inc portfolio CI